Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03430258
Other study ID # 19850703
Secondary ID
Status Not yet recruiting
Phase N/A
First received January 4, 2018
Last updated February 5, 2018
Start date March 1, 2018
Est. completion date March 30, 2019

Study information

Verified date January 2018
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This prospective randomized controlled study was conducted in the emergency intensive care units (EICU) of the second affiliated hospital Zhejiang university school of medicine, a large tertiary university hospital in HangZhou, China.The aim of this randomized study was to compare the effectiveness of high-flow nasal cannula with conventional oxygen therapy in ICU patients with blunt thoracic injury.


Description:

This prospective randomized controlled study was conducted in the emergency intensive care units (EICU) of the second affiliated hospital Zhejiang university school of medicine, a large tertiary university hospital in HangZhou, China.The aim of this randomized study was to compare the effectiveness of high-flow nasal cannula with conventional oxygen therapy in ICU patients with blunt thoracic injury.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date March 30, 2019
Est. primary completion date March 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The trauma registry was used to identify patients with moderate to severe blunt thoracic injury (abbreviated injury scale (AIS) chest score =3) admitted to the ICU

Exclusion Criteria:

1. had intubation and used the mechanical ventilation within 2 hours

2. had the emergency surgerys within 2 hours

3. patients can not accessed by transthoracic lung ultrasound because of the sever aerodermectasia or pneumothorax

4. the Glasgow Coma Scale <8

Study Design


Intervention

Device:
high-flow nasal cannula
high flow of air with supplemental oxygen was delivered by an Optiflow cannula interface using an AIRVO 2 blower humidifier
Conventional oxygen therapy
Conventional oxygen therapy

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Outcome

Type Measure Description Time frame Safety issue
Primary compare the effectiveness of high-flow nasal cannula with conventional oxygen therapy in ICU patients with blunt thoracic injury. High-flow nasal cannula could reduce the intube rate of patients with blunt thoracic injury,and improve the the lung aeration for patients with thoracic injury 72 hours
Secondary number of days in ICU High-flow nasal cannula could reduce the number of days for the patients treatments in ICU 7 days
See also
  Status Clinical Trial Phase
Recruiting NCT05295095 - Does Positive Pressure Extubation Reduce Postoperative Desaturation? N/A
Recruiting NCT02361021 - Lung Aeration During WEANing From Mechanical Ventilation Determined by Electrical Impedance Tomography and Lung Ultrasound N/A
Completed NCT05289960 - Lung Ultrasound Score and Weaning Outcome N/A